Autoantibodies to IA-2β are detected in approximately 40–60% of newly diagnosed T1D patients, typically in conjunction with anti-IA-2 antibodies—a finding attributable to their extensive structural homology. The gene discussed is PTPRN; the disease is type 1 diabetes mellitus.